Acrospire Investment Management LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 82 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2017$26,000
-46.9%
648
-62.9%
0.02%
+5.0%
Q4 2016$49,000
-49.0%
1,748
-46.2%
0.02%
-68.8%
Q3 2016$96,000
+84.6%
3,248
+27.5%
0.06%
+64.1%
Q2 2016$52,0002,5480.04%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2016
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders